D.L. Carlson Investment Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Buy
4,077
+127
+3% +$71.2K 0.34% 76
2026
Q1
$2.22M Buy
3,950
+231
+6% +$148K 0.38% 66
2025
Q4
$2.52M Buy
3,719
+39
+1% +$26.6K 0.42% 64
2025
Q3
$2.35M Buy
3,680
+487
+15% +$296K 0.39% 67
2025
Q2
$1.71M Buy
+3,193
New +$1.53M 0.31% 77

Other funds holding IDXX

D.L. Carlson Investment Group's IDXX Position: Q2 2026 in Review

D.L. Carlson Investment Group increased its Idexx Laboratories (IDXX) stake by 3.2% in Q2 2026, buying an estimated $71.2K and bringing the position to 4,077 shares worth $2.15M. The position accounts for 0.34% of the portfolio, ranked #76.

D.L. Carlson Investment Group first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.52M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • D.L. Carlson Investment Group held 4,077 shares of Idexx Laboratories worth $2.15M as of Q2 2026.
  • D.L. Carlson Investment Group bought 127 Idexx Laboratories shares in Q2 2026, an estimated $71.2K.
  • Idexx Laboratories made up 0.34% of D.L. Carlson Investment Group's portfolio in Q2 2026, its #76 holding.
  • D.L. Carlson Investment Group first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • D.L. Carlson Investment Group's Idexx Laboratories position peaked at $2.52M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.